Advertisement

Pregnancy and Heart Disease for the Consulting Physician

  • Priscilla Givens
  • Gladys Velarde
Chapter

Abstract

As more women are becoming pregnant at an older age, cardiovascular disease (CVD) in the pregnant patient is becoming more common. When evaluating the management strategy of pregnant patients with CVD, it is critical to consider the morbidity and mortality of both the mother and the fetus. Knowledge of normal hemodynamic changes and their effects on the physical exam of the pregnant patient is important for accurate and effective management of these patients. With a rise in the incidence of heart disease in the pregnant population, it is important to utilize a team approach to ensure a safe pregnancy and delivery for both mother and fetus.

Keywords

Pregnancy Cardiovascular disease Preeclampsia Eclampsia Peripartum cardiomyopathy Risk factors Congenital heart disease 

References

  1. 1.
    Regitz-Zagrosek V, Lundqvist CB, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy; The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147–97.CrossRefGoogle Scholar
  2. 2.
    Siu SC, Sermer M, Colman JM. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515–21.CrossRefGoogle Scholar
  3. 3.
    American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.CrossRefGoogle Scholar
  4. 4.
    Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States. 2011-2013. Obstet Gynecol. 2017;130(2):366–73.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J. 1992;68(6):540.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Liu LX, Arany Z. Maternal cardiac metabolism in pregnancy. Cardiovasc Res. 2014;101:545–53.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130:1003–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Chung E, Leinwand LA. Pregnancy as a cardiac stress model. Cardiovasc Res. 2014;101:561–70.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Roberts JM, August PA, Bakris G, et al. Executive summary: hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–31.CrossRefGoogle Scholar
  10. 10.
    Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013;20(3):229–39.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2:CD002252.Google Scholar
  12. 12.
    Alwan S, Polifka JE, Friedman JM. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol. 2005;73(2):123–30.CrossRefPubMedGoogle Scholar
  13. 13.
    Easterling TR, Carr DB, Brateng D, et al. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol. 2001;98(3):427–33.PubMedGoogle Scholar
  14. 14.
    James PR, Nelson-Piercy C. Management of hypertension before, during and after pregnancy. Heart. 2004;90:1499–504.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Firoz T, Magee LA, MacDonell K, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. Int J Obstet Gnaecol. 2014;121(10):1210–8.  https://doi.org/10.1111/1471-0528.12737.CrossRefGoogle Scholar
  16. 16.
    Orbach H, Matok I, Gorodischer R, et al. Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol. 2013;208(3):301.e1–6.CrossRefGoogle Scholar
  17. 17.
    Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Magee LA, von-Dadelszen P, Ch B, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;327(5):407–17.CrossRefGoogle Scholar
  19. 19.
    Padymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51:960–9.CrossRefGoogle Scholar
  20. 20.
    Cruz MO, Gao W, Hibbard JU. What is the optimal time for delivery in women with gestational hypertension. Am J Obstet Gynecol. 2012;207:214.e1–6.CrossRefGoogle Scholar
  21. 21.
    Broekhuijsen K, van Baaren GJ, van Pampus MG, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomized controlled trial. Lancet. 2015;385:2492–501.CrossRefPubMedGoogle Scholar
  22. 22.
    Cruz MO, Gao W, Hibbard JU. Obstetrical and perinatal outcomes among women with gestational hypertension, mild preeclampsia, and mild chronic hypertension. Am J Obstet Gynecol. 2011;205:260.e1–9.CrossRefGoogle Scholar
  23. 23.
    Fisher SD, Etherington A, Schwartz DB, et al. Peripartum cardiomyopathy: an update. Prog Pediatr Cardiol. 2008;25:79–84.CrossRefGoogle Scholar
  24. 24.
    Murali S, Baldisseri R. Perpartum cardiomyopathy. Crit Care Med. 2005;33(10):S340–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States. J Am Coll Cardiol. 2011;58(7):659–70.CrossRefPubMedGoogle Scholar
  26. 26.
    Hu CL, Li YB, Zou YG, et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart. 2007;93:488.CrossRefPubMedGoogle Scholar
  27. 27.
    Modi KA, Illum S, Jariatul K, et al. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol. 2009;201:171.e1–5.CrossRefGoogle Scholar
  28. 28.
    Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152:509–13.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Habli M, O’Brien T, Nowack E, et al. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol. 2008;199:415.e1–5.CrossRefGoogle Scholar
  30. 30.
    Fett JD, Sannon H, Thelisma E, et al. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynecol Obstet. 2009;104:125–7.CrossRefGoogle Scholar
  31. 31.
    Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.CrossRefPubMedGoogle Scholar
  32. 32.
    Ersboll AS, Damm P, Gustafsson F, et al. Peripartum cardiomyopathy: a systematic literature review. Acta Obstet Gynecol Scand. 2016;95:1205–19.CrossRefPubMedGoogle Scholar
  33. 33.
    Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;268:687–93.CrossRefGoogle Scholar
  34. 34.
    Chapa JB, Heiberger HB, Weinert L, et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105:1303.CrossRefPubMedGoogle Scholar
  35. 35.
    Pieper PG. Use of medications for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12:718–29.CrossRefPubMedGoogle Scholar
  36. 36.
    Wright D, Kenny-Scherber C, Montgomery A, Salehian O. Acute coronary syndrome in pregnancy. Clin Med Cardiol. 2009;3:125–31.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Lameijer H, Kampman MAM, Oudijk MA, Pieper PG. Ischaemic heart disease during pregnancy or post-partum: systematic review and case series. Neth Heart J. 2015;23:249–57.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Tweet MS, Hayes SN, Pitta SR, et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012;126:579–88.CrossRefPubMedGoogle Scholar
  39. 39.
    Saw J, Aymong E, Sedlak T, et al. Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv. 2014;7:645–55.CrossRefPubMedGoogle Scholar
  40. 40.
    Reimold SC, Rutherford JD. Clinical Practice. Valvular heart disease in pregnancy. N Engl J Med. 2003;349(1):52–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014. 2014;63:e57–185.CrossRefGoogle Scholar
  42. 42.
    Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation. 2008;118:e523–661.CrossRefPubMedGoogle Scholar
  43. 43.
    Maganti K, Rigolin VH, Sarano ME, et al. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010;85(5):483–500.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Anthony J, Osman A, Sani MU. Valvular heart disease in pregnancy. Cardiovasc J Afr. 2016;27:111–8.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Nishimura RA, Warnes CA. Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions. Heart. 2015;101(6):430–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7:961–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Page RL, Joglar LA, Caldwell MA. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67(13):e27–e115.CrossRefPubMedGoogle Scholar
  48. 48.
    Joglar JA, Page RL. Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf. 1999;20:85–94.CrossRefPubMedGoogle Scholar
  49. 49.
    Joglar JA, Page RL. Management of arrhythmia syndromes during pregnancy. Curr Opin Cardiol. 2014;29:36–44.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Priscilla Givens
    • 1
  • Gladys Velarde
    • 2
  1. 1.North Florida Regional Medical CenterGainesvilleUSA
  2. 2.Division of Cardiology, Department of MedicineUF Health JacksonvilleJacksonvilleUSA

Personalised recommendations